About AVT
Browse Articles
Customer Services

Advanced Publication

Antiviral Therapy publishes articles here before they are finally assigned to an issue. The articles are listed by online publication date and can be cited via a doi.
Displaying 105 results:

Original article

A randomized trial in healthy subjects to assess the bioequivalence of an atazanavir/cobicistat fixed-dose combination tablet versus administration as separate agents

Heather Sevinsky, Xiaolu Tao, Reena Wang, Palanikumar Ravindran, Karen Sims, Xiaohui Xu, Navin Jariwala, Richard Bertz


Original article

Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection

Joseph J Eron, David A Cooper, Roy T Steigbigel, Bonaventura Clotet, Patrick Yeni, Kim M Strohmaier, Anthony Rodgers, Richard J Barnard, Bach-Yen T Nguyen, Hedy Teppler, the BENCHMRK Study Teams


Original article

Can antiretroviral therapy modify the clinical course of HDV infection in HIV-positive patients?

Simona Onali, Francesco Figorilli, Cinzia Balestrieri, Giancarlo Serra, Maria Conti, Rosetta Scioscia, Lucia Barca, Maria E Lai, Luchino Chessa



The clinical management of HCV in the HIV-infected patient

Brianna Norton, Susanna Naggie


Original article

Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada

Katherine J Lepik, Benita Yip, Rachel A McGovern, Erin Ding, Adriana Nohpal, Birgit E Watson, Junine Toy, Linda Akagi, P Richard Harrigan, David M Moore, Robert S Hogg, Julio SG Montaner, Rolando Barrios



Viral resistance of MOGS-CDG patients implies a broad-spectrum strategy against acute virus infections

Jinhong Chang, Timothy M Block, Ju-Tao Guo


Short communication

Genotype F of hepatitis B: response to interferon

Mauricio Venegas, Jaime Poniachik, Francisco Fuster, Carmen Hurtado, Rodrigo A Villanueva, Javier Brahm


Original article

Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive patients

Kirsten L White, Rima Kulkarni, Damian J McColl, Martin S Rhee, Javier Szwarcberg, Andrew K Cheng, Michael D Miller


Original article

A pharmacokinetic/viral kinetic model to evaluate the treatment effectiveness of danoprevir against chronic HCV

Laetitia Canini, Anushree Chatterjee, Jeremie Guedj, Annabelle Lemenuel-Diot, Barbara Brennan, Patrick F Smith, Alan S Perelson


Short communication

Dolutegravir versus placebo in subjects harbouring HIV-1 with integrase inhibitor resistance associated substitutions: 48-week results from VIKING-4, a randomized study

Bisher Akil, Gary Blick, Debbie P Hagins, Moti N Ramgopal, Gary J Richmond, Rafik M Samuel, Naomi Givens, Cindy Vavro, Ivy H Song, Brian Wynne, Mounir Ait-Khaled, the VIKING-4 study team


Copyright © Nucleus Global 2014. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.